@hswapnil @nupur_nephron @PD_Perls @eric_weinhandl @NephJC @OttawaRenal Not that wishy washy. Agree that loop should probably be first, but why spironolactone before ACEi? Too much hypokalemia? #Nephjc https://t.co/wjgCrOIs6g https://t.co/3fqoUMtkyd
@nephron84 don't believe those small Japanese trials in PD - or the Cochrane SR either (https://t.co/qWCWqfyM20) Also see https://t.co/0dgaDJAh5l Use ARBs for BP or CV indications perhaps. Not for RRF preservation (PD or HD)
@docpro89 @Maximal_Change @Errantnephron @askrenal @NephJC @STOPACEi_trial Yes definitely use RAAS blockade to preserve residual kidney function 👍👍 On a related note, you do still need to watch out for hyperkalemia in ESRD patients as RAASi can mess with g
Les inhibiteurs de l'enzyme de conversion de l'angiotensine et les antagonistes des récepteurs de l'angiotensine... http://t.co/9CsOvXbMQ8
腹膜透析患者へのACEi/ARBによる残留腎機能保護能は同等.コクランからの報告. | Angiotensin-converting enzyme inh... [Cochrane Database Syst Rev. 2014] http://t.co/LNBmduoF7D
(Cochrane) Evidencia insuficiente para recomendar IECA/ARAII de 1ª elección en pac sometidos a diálisis peritoneal http://t.co/ekm2PJsK6F